by Staff | Oct 17, 2023 | Press Releases
Non-Dilutive Funding and Resources Provided to De-Risk Investment and Accelerate Commercialization October 17, 2023 10:00 ET| Source: Invizyne Technologies, Inc. Monrovia, CA, Oct. 17, 2023 (GLOBE NEWSWIRE) — Invizyne Technologies, Inc., a leading designer of...
by Staff | Oct 11, 2023 | Press Releases
Funding Supports Project to Optimize and Scale Up Isobutanol Production to Address Potential $27.4 Billion Sustainable Aviation Fuel Market October 11, 2023 11:10 ET| Source: Invizyne Technologies, Inc. Monrovia, CA, Oct. 11, 2023 (GLOBE NEWSWIRE) — Invizyne...
by Staff | Jun 15, 2023 | Press Releases
DALLAS, TX / ACCESSWIRE / June 15, 2023 / Public Ventures, LLC, a wholly owned subsidiary of MDB Capital Holdings, LLC, today announced it received official approval on May 31 to become both a Participant as set forth by the rules, by-laws and organization certificate...
by Staff | May 5, 2023 | Press Releases
HeartBeam to Focus on Becoming the Global Leader in Ambulatory Vectorcardiography, the Highest Resolution ECG Monitoring Platform Funding to Enable Company to Execute on Upcoming Clinical, Regulatory and Commercial Milestones, Extends Cash Runway into Late 2024...
by Staff | Nov 29, 2022 | Press Releases
DALLAS, T.X. / ACCESSWIRE / November 29, 2022 / MDB Capital Holdings, LLC, a privately-held public venture platform with the objective of growing the public venture marketplace and optimizing the way meaningful technologies are financed and built, today announced that...
by Staff | Nov 17, 2022 | Press Releases
DALLAS, TX / ACCESSWIRE / November 17, 2022 / Public Ventures, LLC, a wholly owned subsidiary of MDB Capital Holdings, LLC, completed its first financing as a broker-dealer for Cue Biopharma, Inc. (NASDAQ:CUE). The Public Ventures’ portion of the financing was...
Recent Comments